REIN THERAPEUTICS ENTERS INTO AGREEMENTS FOR UP TO $21 MILLION IN FLEXIBLE FINANCING
REIN THERAPEUTICS INC - PROCEEDS TO SUPPORT RENEW PHASE 2 TRIAL OF LTI-03 FOR IPF
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.